Neurologian yksikkö
Department of Neurology

Julkaisut 1991-1991
Publications 1991-1991

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Sirviö J, Riekkinen P, Ylinen A, Airaksinen MM, eds. 5th Nordic Neuroscience Meeting. Kuopio, June 12-15, 1991. Proceedings. Kuopion yliopiston julkaisuja. Lääketiede. Tilastot ja selvitykset 2/1991. 201 s
2 Koponen H, Riekkinen P. Acute confusional states in the elderly. Kirjassa: Seva A et al., eds. The European Handbook of Psychiatry and Mental Health II, s. 1694-1701. Barcelona: Editorial Anthropos, 1991
3 Viinamäki H, Koivisto K, Riekkinen P. Aivohalvauksen jälkeinen depressio. Suomen Lääkärilehti 1991:46:127-130.
4 Riekkinen P Sr, Soininen H, Sirviö J, Riekkinen P Jr. Aivotutkimuksen tulevaisuuden näkymät. Lääkeuutiset 1991:4:267-271.
5 Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: A collaborative re-analysis of case control studies. Int J Epidemiol 1991:20:Suppl 2.
6 Riekkinen P Jr, Sirviö J, Koivisto E, Lammintausta R, Riekkinen P. Alpha2-noradrenergic and basal forebrain cholinergic regulation of thalamic high-voltage spindles. Kuopion yliopiston julkaisuja. Lääketiede. Tilastot ja selvitykset 2/1991:28-29
7 Halonen T, Pitkänen A, Partanen J, Hyttinen JM, Riekkinen PJ. Amino acid levels in cerebrospinal fluid of rats after administration of pentylenetetrazol. Comp Biochem Physiol 1991:101:21-25
8 Henriksson T, Barbour RM, Braa S, Ward P, Fritz LC, Johnson-Wood K, Chung HD, Burke W, Reinikainen KJ, Riekkinen PJ, Schenk DB. Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with monoclonal antibody-based immunoassay. J Neurochem 1991:56:1037-1042.
9 Sivenius J, Riekkinen PJ, Kilpeläinen H, Laakso M, Penttilä I. Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European stroke prevention study (ESPS). Acta Neurol Scand 1991:84:286-290.
10 Ylinen A, Lahtinen H, Sirviö J, Partanen J, Asikainen A, Gulyas A, Freund TF, Riekkinen P. Behavioural, electrophysiological and histopatological changes following sustained stimulation of the perforant pathway input to the hippocampus: effect of the NMDA receptor antagonist.. Brain Res 1991:553:195-200.
11 Koponen H, Riekkinen PJ. Cerebrospinal fluid acetylcholinesterase in patients with dementia associated with schizophrenia or chronic alcoholism. Acta Psychiatr Scand 1991:83:441-443.
12 Koponen H, Riekkinen PJ. Cerebrospinal fluid beta-endorphin-like immunoreactivity in patients with dementia associated with schizophrenia and chronic alcoholism. Nord Psykiatr Tidsskr 1991:45:309-311
13 Soininen H, Partanen J, Pääkkönen A, Koivisto E, Riekkinen PJ. Changes in absolute power values of EEG spectra in the follow-up of Alzheimer's disease. Acta Neurol Scand 1991:83:133-136.
14 Soininen H, Partanen J, Helkala E-L, Laulumaa V, Reinikainen K, Riekkinen PJ. Cholinergic system and EEG: human studies. Kuopion yliopiston julkaisuja. Lääketiede. Tilastot ja selvitykset 2/1991:40-44
15 Riekkinen P, Buzsaki G, Riekkinen P Jr, Soininen H, Partanen J. The cholinergic system and EEG slow waves. Review article. Electroencephalogr Clin Neurophysiol 1991:78:89-96.
16 Koponen H, Riekkinen PJ. Clinical course and long-term prognosis of non-alcohol delirium in elderly patients. Psychiatr Fenn 1991:22:37-45.
17 Riekkinen P Jr, Riekkinen M, Jäkälä P, Sirviö J, Lammintausta R, Riekkinen P. Combination of atipamezole and tetrahydroaminoacridine/pilocarpine treatment suppresses high voltage spindle activity in aged rats. Brain Res Bull 1991:27:237-239.
18 Riekkinen M, Riekkinen P Jr, Riekkinen P. Comparison of quisqualic and ibotenic acid nucleus basalis magnocellularis lesions on water-maze and passive avoidance performance. Brain Res Bull 1991:27:119-123.
19 Riekkinen P Jr, Riekkinen M, Sirviö J, Miettinen R, Riekkinen P. Comparison of the effects of acute and chronic ibotenic and quisqualic acid nucleus basalis lesioning. Brain Res Bull 1991:27:199-206.
20 Jolkkonen J, Hartikainen P, Soikkeli R, Bissette G, Nemeroff C, Riekkinen P. A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease. Neuropeptides 1991:19:97-102.
21 Pitkänen A, Amaral DG. Demonstration of projections from the lateral nucleus to the basal nucleus of the amygdala: a PHA-L study in the monkey. Exp Brain Res 1991:83:465-470
22 Helkala EL, Laulumaa V, Soininen H, Partanen J, Riekkinen PJ. Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer's disease. Neurology 1991:41:528-532.
23 Alhainen K, Partanen J, Reinikainen K, Laulumaa V, Soininen H, Airaksinen M, Riekkinen P Sr. Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease. Neurosci Lett 1991:127:113-116.
24 Pitkänen A, Amaral DG. Distribution on reduced nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d) cells and fibers in the monkey amugdaloid complex. J Comp Neurol 1991:313:326-348.
25 Sivenius J, Kälviäinen R, Ylinen A, Riekkinen PJ. Double-blind study of Gabapentin in the treatment of partial seizures. Epilepsia (NY) 1991:32:539-542.
26 Riekkinen P Jr, Sirviö J, Riekkinen M, Riekkinen P. EEG changes induced by acute and chronic quisqualic or ibotenic acid nucleus basalis lesions are stabilized by tacridine. Brain Res 1991:559:304-308.
27 Sirviö J, Ylinen A, Lahtinen H, Ronkainen A, Riekkinen P Jr, Halonen T, Riekkinen PJ. The effect of subchronic administration of Vigabatrin on learning and memory in nonepileptic rats. Pharmacol Biochem Behav 1991:39:205-210.
28 Alhainen K, Riekkinen P Sr, Helkala E-L, Partanen J, Laulumaa V, Reinikainen K, Soininen H, Airaksinen MM. The effect of THA on cognitive functions and spectral power EEG in Alzheimer's disease: Preliminary results of on open study. Kirjassa: Igbal K et al, eds. Alzheimer's Disease: Basic Mechanismus, Diagnosis and Therapeutic Strategies, s. 611-619. Chichester: Wiley, 1991
29 Airaksinen MM, Nieminen SA, MacDonald EJ, Sirviö J, Riekkinen PJ Jr. Effects of alpha2-adrenoreceptor agonist and antagonist on spatial memory in rats. Adv Biosci 1991:82:79-80.
30 Riekkinen P Jr, Sirviö J, Jäkälä P, Riekkinen M, Lammintausta R, Riekkinen P. Effects of alpha2-drugs and pilocarpine on the high-voltage spindle activity of young and aged control and DSP4-lesioned rats. Physiol Behav 1991:50:955-959.
31 Sirviö J, Lukkarinen K, Riekkinen P Jr, Koivisto E, Virtanen R, Pennanen A, Valjakka A, Riekkinen PJ. The effects of atipamezole, an alpha-2 antagonist, on the performance of young and aged rats in the delayed nonmatcing to position task. Pharmacol Biochem Behav 1991:39:1015-1019.
32 Riekkinen P Jr, Sirviö J, Valjakka A, Riekkinen M, Lammintausta R, Riekkinen P. Effects of atipamezole and tetrahydroaminoacridine on nucleus basalis lesion-induced EEG changes. Brain Res Bull 1991:27:231-235.
33 Sirviö J, Riekkinen P Jr, Vajanto I, Koivisto E, Riekkinen PJ. The effects of guanfacine, alpha-2 agonist, on the performance of young and aged rats in spatial navigation task. Behav Neural Biol 1991:56:101-107.
34 Riekkinen P Jr, Jäkälä P, Sirviö J, Riekkinen P. The effects of increased serotonergic and decreased cholinergic activities on spatial navigation performance in rats. Pharmacol Biochem Behav 1991:39:25-29.
35 Sirviö J, Riekkinen P Jr, Valjakka A, Jolkkonen J, Riekkinen PJ. The effects of noradrenergic neurotoxin, DSP-4 on the performance of young and aged rats in spatial navigation task. Brain Res 1991:563:297-302.
36 Aaltonen M, Riekkinen P, Sirviö J, Riekkinen P Jr. Effects of THA on passive avoidance and spatial performance in quisqualic acid nucleus basalis-lesioned rats. Pharmacol Biochem Behav 1991:39:563-568.
37 Riekkinen P Jr, Sirviö J, Riekkinen M, Riekkinen P. Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats. Pharmacol Biochem Behav 1991:39:841-846.
38 Riekkinen P Jr, Jäkälä P, Sirviö J, Koivisto E, Miettinen R, Riekkinen P. The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing. Brain Res Bull 1991:26:633-637.
39 Halonen T, Pitkänen A, Saano V, Riekkinen PJ. Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related aminoacids and on GABA and benzodiazepine receptor binding in rats. Epilepsia (NY) 1991:32:242-249.
40 Nousiainen U, Partanen J, Koivisto K, Soininen H, Riekkinen PJ. Electromyographic findings in patients with Alzheimer's disease. Electromyogr Clin Neurophysiol 1991:31:119-122.
41 Ylinen EMA, Miettinen R, Pitkänen A, Gulyas AI, Freund TF, Riekkinen PJ. Enhanced GABAergic inhibition preserves hippocampal structure and function in a model of epilepsy. Proc Natl Acad Sci U S A 1991:88:7650-7653.
42 Koponen H, Honkonen S, Partanen J, Riekkinen PJ. Epileptic attack, delirium, and a Creutzfeldt-Jakob-like syndrome during mianserin treatment. Neuropsychobiology 1991:23:164-168.
43 Koponen H, Honkonen S, Partanen J, Riekkinen PJ. Epileptic attack, delirium, and periodic complexes in the EEG during mianserin treatment. J Neurol Neurosurg Psychiatry 1991:54:379.
44 Sivenius J, Riekkinen PJ Sr, Smets P, Laakso M, Lowenthal A. The European Stroke Prevention Study (ESPS): Results by arterial distribution. Ann Neurol 1991:29:596-600.
45 Sivenius S, Laakso M, Penttilä IM, Smets P, Lowenthal A, Riekkinen PJ. The European Stroke Prevention Study: Results according to sex. Neurology 1991:41:1189-1192.
46 Valjakka A, Koivisto E, Riekkinen P. Evoked field responses and awake immobility-related non-rhythmical EEG in hippocampus of young and aged rats. Neurosci Res Comm 1991:8:29-35
47 Valjakka A, Lukkarinen K, Koivisto E, Lammintausta R, Airaksinen MM, Riekkinen P. Evoked field responses, recurrent inhibition, long-term potentiation and immobility-related nonrhytmical EEG in the dentate gyrus of fimbria-fornix-lesioned and control rats. Brain Res Bull 1991:26:525-532.
48 van Duijn CM, Clayton D, Chandra V, Fragtiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A. Familial aggregation of Alzheimer's disease and related disorders: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991:20:Suppl 2.
49 Riekkinen P Jr, Sirviö J, Riekkinen M, Valjakka A, Koivisto E, Riekkinen P. Gammavinylgaba increases high voltage spindle activity in control and nucleus basalis-lesioned rats after sub-chronic treatment. Brain Res 1991:565:341-344.
50 Koponen H, Honkonen S, Partanen J, Riekkinen PJ. Greutzfeldt-Jakobin taudin kaltainen oireisto mianseriinihoidon aikana. Duodecim 1991:107:173-175.
51 Mortimer JA, van Duijn CM, Chandra V, Fratiqlioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Rocca WA, Shalat SL, Soininen H, Hofman A. Head trauma as a risk factor for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991:20:Suppl 2.
52 Ylinen A, Koivisto E, Valjakka A, Sirviö J, Freund TF, Riekkinen P. Hippocampal mobility-related theta activity is not diminished by Vigabatrin, a GABAmimetic antiepileptic drug, in normal rats. Brain Res Bull 1991:28:145-147.
53 Ylinen A. Hippocampal reactions and their pharmacotherapy in experimental epilepsy. University of Kuopio. Series of Reports. Department of Neurology 21. 75 s., liitt
54 Airaksinen MS, Paetau A, Paljärvi L, Reinikainen K, Riekkinen P, Suomalainen R, Panula P. Histamine neurons in human hypothalamus: Anatomy in normal and Alzheimer diseased brains. Neuroscience 1991:44:465-481.
55 Riekkinen P Jr, Sirviö J, Jäkälä P, Mazurkiewicz M, Valjakka A, Riekkinen M, Riekkinen P. Increased GABAergic transmission aggravates nucleus basalis magnocellularis lesion-induced behavioral deficits. Brain Res Bull 1991:27:287-289.
56 Riekkinen P Jr, Koivisto E, Sirviö J, Riekkinen P. Joint modulation of neocortical electrical activity by nicotinic and muscarinic receptors. Brain Res Bull 1991:27:137-139.
57 Rocca WA, van Duijn CM, Clayton D, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo E, Mortimer JA, Shalat SL, Soininen H, Hofman A. Maternal age and Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991:20:Suppl 2.
58 European Carotid Surgery Trialists' Collaborative Group, incl. Hartikainen P, Koivisto K, Oksala I, Riekkinen P, Sivenius J. MCR European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991:337:1235-1243.
59 Breteler MMB, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A. Medical history and the risk of Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991:20:Suppl 2.
60 Valjakka A, Lukkarinen K, Koivisto E, Riekkinen P Jr, Miettinen R, Airaksinen MM, Lammintausta R, Riekkinen P. Modulation of EEG rhytmicity and spike activity in the rat hippocampus by systemically administered tetrahydroaminoacridine, scopolamine and atipamezole. Brain Res Bull 1991:26:739-745.
61 Sirviö J, Rakonczay Z, Hartikainen P, Kasa P, Riekkinen PJ. The molecular forms of acetylcholinesterase in cerebrospinal fluid of normal subjects - effect of aging. J Neural Transm 1991:86:147-150
62 Hartikainen P, Soininen H, Reinikainen KJ, Sirviö J, Soikkeli R, Riekkinen PJ. Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors. J Neural Transm 1991:84:103-117
63 Reinikainen K, Soininen H, Paljärvi L, Riekkinen P Sr. Neurotransmitter markers in the cerebrospinal fluid of patients with histologically verified Alzheimer's disease. Kirjassa: Iqbal K et al., eds. Alzheimer's Disease: Basic Mechanismus, Diagnosis and Therapeutic Strategies, s. 525-532. Chichester: Wiley, 1991
64 Riekkinen P Jr, Sirviö J, Riekkinen P. Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate. Psychopharmacology 1991:103:567-570.
65 Graves AB, van Duijn CM, Chandra V, Fragtiglioni L, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A. Occupational exposures to solvents and lead as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991:20:Suppl 2.
66 Suomalainen T, Vapalahti M, Nousiainen U, Sivenius J, Hurskainen H, Partanen J, Puranen M, Rinne J, Mervaala E, Lepola U, Paljärvi L. Ohimolohkoepilepsian leikkaushoito. Duodecim 1991:107:917-924.
67 Freund TF, Ylinen A, Miettinen R, Pitkänen A, Lahtinen H, Baimbridge KG, Riekkinen PJ. Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability. Brain Res Bull 1991:28:27-38.
68 Riekkinen P Jr, Sirviö J, Valjakka A, Miettinen R, Riekkinen P. Pharmacological consequences of cholinergic plus serotonergic manipulations. Brain Res 1991:552:23-26.
69 Jorm AF, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A. Psychiatric history and related exposures as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991:20:Suppl 2.
70 Kälviäinen R, Äikiä M, Partanen J, Sivenius J, Mumrord J, Saksa M, Riekkinen PJ. Randomized controlled pilot study of Vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report. J Child Neurol 1991:6:60-69.
71 Alhainen KJ, Riekkinen PJ Jr, Soininen HS, Reinikainen KJ, Riekkinen PJ Sr. Responders and nonresponders in experimental therapy of Alzheimer's disease. Kirjassa: Becker R, Giacobini E, eds. Cholinergic basis for Alzheimer therapy, s. 213-237. Boston: Birkhäuser, 1991
72 Soininen H, Partanen J, Laulumaa V, Pääkkönen A, Helkala EL, Riekkinen PJ. Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome. Electroencephalogr Clin Neurophysiol 1991:79:342-348.
73 Syrjänen S, Heinonen O, Miettinen R, Paljärvi L, Syrjänen K, Riekkinen P. Short biotinylated oligonucleotides bind non-specifically to senile plaques of Alzheimer's disease. Neurosci Lett 1991:130:89-91.
74 Soikkeli R, Partanen J, Soininen H, Pääkkönen A, Riekkinen P Sr. Slowing of EEG in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1991:79:159-165.
75 Helkala EL, Laulumaa V, Soikkeli R, Partanen J, Soininen H, Riekkinen PJ. Slow-wave activity in the spectral analysis of the electroencephalogram is associated with cortical dysfunctions in patients with Alzheimer's disease. Behav Neurosci 1991:105:409-415.
76 Alhainen K, Sirviö J, Helkala EL, Reinikainen K, Riekkinen P Sr. Somatostatin and cognitive functions in Alzheimer's disease - the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine. Neurosci Lett 1991:130:46-48.
77 Murros K. Stress reactions of brain infarction - A prospective study on 105 patients with acute ischemic brain infarction of the internal carotid artery territory. University of Kuopio. Series of Reports. Department of Neurology 20. 77 s
78 Gulyas AI, Toth K, Danos P, Freund TF. Subpopulations of GABAergic neurons containing parvalbumin, calbindin D28k, and cholecystokinin in the rat hippocampus. J Comp Neurol 1991:312:371-378.
79 Riekkinen P Jr, Aaltonen M, Sirviö J, Riekkinen P. Tetrahydroaminoacridine alleviates medial septal lesion-induced and age-related spatial reference but not working memory deficits. Physiol Behav 1991:49:1147-1152.
80 Riekkinen P Jr, Riekkinen M, Lahtinen H, Sirviö J, Valjakka A, Riekkinen P. Tetrahydroaminoacridine improves passive avoidance retention defects induced by aging and medial septal lesion but not by fimbria-fornix lesion. Brain Res Bull 1991:27:587-594.
81 Riekkinen P Jr, Aaltonen M, Riekkinen P. Tetrahydroaminoacridine inhibits high voltage spindle activity in aged rats after acute and chronic treatment. Psychopharmacology 1991:103:265-267.
82 Koponen H, Riekkinen PJ. Vanhusten sekavuustilojen pitkäaikaisennuste. Suomen Lääkärilehti 1991:46:2928-2932.
83 Sivenius J, Ylinen A, Murros K, Mumford JP, Riekkinen PJ. Vigabatrin in drug-resistant partial epilepsy: A 5-year follow-up study. Neurology 1991:41:562-565.
84 Ylinen A, Valjakka A, Lahtinen H, Miettinen R, Freund TF, Riekkinen P. Vigabatrin pre-treatment prevents hilar symatostatin cell loss and the development of interictal spiking activity following sustained simulation of the perforant path. Neuropeptides 1991:19:205-211.
85 Sivenius J, Ylinen A, Riekkinen PJ. Vigabatrin treatment of epilepsy - Reply from the authors. Neurology 1991:41:1855.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 24.1.2013 Publications Data Base 24.1.2013